Literature DB >> 20473698

The effect of Li+ on GSK-3 inhibition: molecular dynamics simulation.

Hao Sun1, Yong-jun Jiang, Qing-sen Yu, Cheng-cai Luo, Jian-wei Zou.   

Abstract

Glycogen synthase kinase-3 (GSK-3) is a kind of serine-threonine protein kinase. It places important roles in several signaling pathways and it is a key therapeutic target for a number of diseases, such as diabetes, cancer, Alzheimer's disease and chronic inflammation. Mg(2+) ions which interact with ATP are conserved in GSK. They are important in phosphoryl transfer. Li(+) is an inhibitor for GSK-3. It is used to treat bipolar mood disorder. This paper illustrates the effect of Li(+) on GSK-3. When Mg(I)(2+) is replaced by Li(+), the atom fluctuation of GSK-3 will rise, and the in-line phosphoryl transfer mechanism is probably demolished and the binding of pre-phosphorylated substrates may be disturbed. All the results we obtained clearly suggest that inhibition to GSK-3 is caused by the Mg(I)(2+) replacement with Li(+).

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20473698     DOI: 10.1007/s00894-010-0738-0

Source DB:  PubMed          Journal:  J Mol Model        ISSN: 0948-5023            Impact factor:   1.810


  23 in total

1.  Crystal structure of glycogen synthase kinase 3 beta: structural basis for phosphate-primed substrate specificity and autoinhibition.

Authors:  R Dajani; E Fraser; S M Roe; N Young; V Good; T C Dale; L H Pearl
Journal:  Cell       Date:  2001-06-15       Impact factor: 41.582

2.  Lithium salts in the treatment of psychotic excitement.

Authors:  J F J CADE
Journal:  Med J Aust       Date:  1949-09-03       Impact factor: 7.738

3.  Specificity and mechanism of action of some commonly used protein kinase inhibitors.

Authors:  S P Davies; H Reddy; M Caivano; P Cohen
Journal:  Biochem J       Date:  2000-10-01       Impact factor: 3.857

4.  Kinetic analyses of mutations in the glycine-rich loop of cAMP-dependent protein kinase.

Authors:  B D Grant; W Hemmer; I Tsigelny; J A Adams; S S Taylor
Journal:  Biochemistry       Date:  1998-05-26       Impact factor: 3.162

5.  Lithium inhibits glycogen synthase kinase-3 by competition for magnesium.

Authors:  W J Ryves; A J Harwood
Journal:  Biochem Biophys Res Commun       Date:  2001-01-26       Impact factor: 3.575

6.  Glycogen synthase kinase-3 inhibition by lithium and beryllium suggests the presence of two magnesium binding sites.

Authors:  W Jonathan Ryves; Rana Dajani; Laurence Pearl; Adrian J Harwood
Journal:  Biochem Biophys Res Commun       Date:  2002-01-25       Impact factor: 3.575

7.  A molecular mechanism for the effect of lithium on development.

Authors:  P S Klein; D A Melton
Journal:  Proc Natl Acad Sci U S A       Date:  1996-08-06       Impact factor: 11.205

8.  Requirement for glycogen synthase kinase-3beta in cell survival and NF-kappaB activation.

Authors:  K P Hoeflich; J Luo; E A Rubie; M S Tsao; O Jin; J R Woodgett
Journal:  Nature       Date:  2000-07-06       Impact factor: 49.962

9.  Dissection of the nucleotide and metal-phosphate binding sites in cAMP-dependent protein kinase.

Authors:  F W Herberg; M L Doyle; S Cox; S S Taylor
Journal:  Biochemistry       Date:  1999-05-11       Impact factor: 3.162

10.  The mechanism of inhibition of the cyclin-dependent kinase-2 as revealed by the molecular dynamics study on the complex CDK2 with the peptide substrate HHASPRK.

Authors:  Iveta Bártová; Michal Otyepka; Zdenek Kríz; Jaroslav Koca
Journal:  Protein Sci       Date:  2005-01-04       Impact factor: 6.725

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.